Walleye Trading LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$80,028
-52.6%
16,200
+3.2%
0.00%
Q3 2022$169,000
-1.2%
15,700
-16.4%
0.00%
Q1 2022$171,000
-54.3%
18,771
+31.2%
0.00%
-100.0%
Q2 2021$374,000
+36.0%
14,310
+83.5%
0.00%
+100.0%
Q1 2021$275,000
+12.2%
7,800
+20.0%
0.00%0.0%
Q3 2020$245,000
-31.8%
6,500
-22.6%
0.00%
-50.0%
Q2 2020$359,0008,4000.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders